Derek Gregory Batcheller

Derek Gregory Batcheller is the founder of Laccure AB, founded in 2007, and Trophea AB, founded in 2015.
Current jobs include Chief Executive Officer at Stanbridge Corp.
BV since 2007; Chairman at Xintela AB since 2011; Chairman at SAGA Diagnostics AB; Executive Chairman at ImmuneBiotech Medical Sweden AB; Chairman at Targinta AB; Chairman at CarryGenes Therapeutics AB; Chairman at Lundoch Diagnostics AB; Co-Chairman at Edvince AB; Director at CanImGuide Therapeutics AB; Director at Business Research Life Sciences Ltd.; Director at Immodulate Pharma AB; and Partner at Aqilion AB. Former jobs include Chief Executive Officer at Pulsetten AB; Executive Chairman at Abliva AB from 2013 to 2017; Chairman at Preelumina AB; Chairman at Guard Therapeutics International AB; Chairman at AcuCort AB; Chairman at Preelumina Diagnostics AB; Chairman at Monocl AB; Chairman at Intellego Technologies AB from 2023 to 2026; Director at Maas Biolab LLC; Director at Dermafol AB; Director at OVB Freehold Ltd.; and Director at DuoCort AB. Education includes graduate degrees from the University of Toronto and the University of Lund, and an undergraduate degree from the London School of Economics & Political Science.